Optometrists in Mount Vernon, NY Accepting Medicare

8 Optometrists found. Showing 1 - 8

Vivid Vision Optometry Pllc Optometrist Medicare: Medicare Enrolled Practice Location: 500 E Sandford Blvd, Mount Vernon, NY 10550 Phone: 914-297-4337

Mount Vernon Eye Care Optometrist Medicare: Not Enrolled in Medicare Practice Location: 108 Gramatan Ave, Mount Vernon, NY 10550 Phone: 914-663-8010    Fax: 914-663-8010

Carolyn Mohedano-craner, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 105 Stevens Ave, Suite 203, Mount Vernon, NY 10550 Phone: 914-668-7442    Fax: 914-668-4669

Dr. Garren Craner, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 105 Stevens Ave, Suite #203, Mount Vernon, NY 10550 Phone: 914-668-7442

Mount Vernon Optometry Associates, Pc Optometrist Medicare: Medicare Enrolled Practice Location: 105 Stevens Ave, Suite 203, Mount Vernon, NY 10550 Phone: 914-668-7442    Fax: 914-668-4669

Momina Ahmed Shaikh, OD Optometrist Medicare: Medicare Enrolled Practice Location: 51 E Prospect Ave, Mount Vernon, NY 10550 Phone: 914-721-5072

Gramatan Eyecare Optometrist Medicare: Not Enrolled in Medicare Practice Location: 171 Gramatan Ave, Mount Vernon, NY 10550 Phone: 914-667-0147    Fax: 914-664-0205

Dr. Iva H Yalkowsky-kornreich, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 171 Gramatan Ave, Mount Vernon, NY 10550 Phone: 914-664-0205

News Archive

Shape-changing in proteins opens new avenue for drug discovery

Computational biologists at the University of Pittsburgh School of Medicine have shown that proteins have an intrinsic ability to change shape, and this is required for their biological activity. This shape-changing also allows the small molecules that are attracted to a given protein to select the structure that permits the best binding. That premise could help in drug discovery and in designing compounds that will have the most impact on protein function to better treat a host of diseases.

Colonization by SARS-CoV-2 not synonymous with infection, screening study highlights

A new study released as a preprint on the medRxiv* server throws cold water on this notion, however, by demonstrating that in a set of asymptomatic cases, less than a tenth actually had evidence of SARS-CoV-2 infection. This finding has serious implications for the practices mentioned above, since they may be neither justifiable nor cost-effective as means to break the chain of viral transmission.

NTU and TTSH join forces to improve doctor-patient communication

A joint study by researchers from Nanyang Technological University, Singapore and clinicians at Tan Tock Seng Hospital has yielded insights into how doctors can better communicate the value of clinical investigations to patients.

Schering-Plough receives FDA complete response letter regarding PEGINTRON

Schering-Plough Corp. announced the U.S. Food and Drug Administration (FDA) has issued a complete response letter to the company's supplemental Biologics License Application regarding PEGINTRON® (pegylated interferon alfa-2b) for the adjuvant treatment of patients with stage III malignant melanoma after complete lymphadenectomy.

NHCS researchers develop human heart cell model of ARVC

Researchers at the National Heart Centre Singapore (NHCS) have successfully created a human heart cell model of arrhythmogenic right ventricular cardiomyopathy (ARVC), an inherited heart muscle disorder which puts one at high risk of developing life-threatening arrhythmias and sudden cardiac death.

Read more Medical News

› Verified 1 days ago